Liebert Debra K. 4
4 · Milestone Pharmaceuticals Inc. · Filed Oct 21, 2022
Insider Transaction Report
Form 4
Liebert Debra K.
Director
Transactions
- Purchase
Common Shares
2022-10-21$5.26/sh+4,000$21,040→ 4,000 total(indirect: By Trust) - Purchase
Common Shares
2022-10-20$5.29/sh+10,000$52,900→ 10,000 total(indirect: By Trust)
Holdings
- 127
Common Shares
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.24 to $5.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]These shares are held in a trust for the benefit of several including the Reporting Person's spouse. The Reporting Person's spouse is a co-executor of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.